Industry News
28 Sep
Cell & Gene Therapy 2030: From Scientific Innovation to Commercial Scale
Cell and gene therapy (CGT) has moved from being primarily an experimental frontier to an increasingly established therapeutic modality. The scientific question is no longer simply whether cells or genetic material can be engineered to treat disease. The larger strategic question is whether these therapies can be manufactured consistently, regulated efficiently, delivered to patients, and […]
25 Sep
FDA Updates Regulations to Advance Alternatives to Animal Testing
Industry: Pharmaceuticals | Biotechnology | Regulatory Intelligence | Drug Development The U.S. Food and Drug Administration (FDA) has taken another significant step toward modernizing nonclinical drug development by updating its regulations to formally recognize a broader range of testing approaches beyond traditional animal studies. On September 21, 2026, the FDA issued a direct final rule […]
24 Sep
FDA Approves First Gene Therapy for Sanfilippo Syndrome Type A
A New Milestone for Rare Disease Treatment The U.S. Food and Drug Administration (FDA) has approved FAYUVI (rebisufligene etisparvovec-hopf), developed by Ultragenyx Pharmaceutical, for pediatric patients with mucopolysaccharidosis type IIIA (MPS IIIA), also known as Sanfilippo syndrome type A. The September 17, 2026 approval represents the first FDA-approved treatment for MPS IIIA and introduces a […]
23 Sep
What the 2026 FDA Expedited IND Pilot Means for Pharma Strategy
The pharmaceutical industry is entering a period in which regulatory strategy may increasingly influence not only compliance but also the speed and economics of innovation. The U.S. FDA’s 2026 Expedited Investigational New Drug (IND) Pilot Program is an important example of this shift. Launched on September 15, 2026 under HHS’s Operation TrialBlazer, the pilot is […]
22 Sep
Is Platform Technology Becoming More Valuable Than Individual Biotechnology Products?
Biotechnology has traditionally been evaluated through the lens of individual products: a novel therapy, a breakthrough diagnostic, a proprietary enzyme, or a differentiated biological ingredient. However, the economics of the biotechnology industry are increasingly creating a different strategic question: Is the platform behind the product becoming more valuable than the product itself? A successful biotechnology […]
21 Sep
Is Precision Fermentation Expanding Beyond Food Into High-Value Industrial Applications?
Precision fermentation is rapidly evolving from a food technology into a broader industrial biotechnology platform. Once primarily associated with alternative proteins, dairy proteins, and functional food ingredients, the technology is now attracting interest across cosmetics, pharmaceuticals, specialty chemicals, biomaterials, nutrition, and other high-value applications. This evolution could fundamentally change how companies manufacture complex biological and […]
18 Sep
Is India Becoming a Strategic Manufacturing Hub for Global Automakers?
India is increasingly moving beyond its traditional role as a large automotive consumer market and emerging as an important manufacturing, engineering, and export base for global automakers. The shift is being driven by several forces at once: expanding domestic vehicle demand, growing supplier capabilities, government manufacturing incentives, increasing localization, electric-mobility investment, and the strategic need […]
09 Sep
Will Chinese EV Competition Force European Automakers to Rethink Global Strategy?
The global automotive industry is entering a period of structural change. Electric vehicles (EVs), battery technology, software-defined vehicles, connected mobility, and increasingly competitive Asian manufacturers are reshaping the traditional automotive value chain. Among the most important developments is the growing international presence of Chinese EV manufacturers. Companies such as BYD, SAIC, Geely, NIO, XPeng, and […]
08 Sep
Can Functional Ingredients Transform Traditional Food Categories?
The global food industry is undergoing a fundamental transformation. Consumers are no longer choosing products solely based on taste, convenience, price, or brand recognition. Increasingly, they are looking for foods that deliver additional health and wellness benefits. This shift is creating significant opportunities for functional ingredients—bioactive compounds, fibers, probiotics, proteins, vitamins, minerals, plant extracts, and […]
04 Sep
Will Chinese EV Competition Force European Automakers to Rethink Global Strategy?
The global automotive industry is undergoing one of its most significant competitive transformations in decades. The rapid expansion of Chinese electric vehicle (EV) manufacturers is challenging established automotive leaders across technology, pricing, manufacturing, supply chains, and international market strategy. For European automakers, the challenge extends far beyond competition in the EV segment. It raises a […]